sftd

Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections

Filed in archive Bacteria and Bacterial Infections , FDA Approvals , Treatment on October 18, 2007

Currently, the prescribed medication for the treatment of complicated urinary tract infections is levofloxacin while meropenem for complicated intra-abdominal infections.

7769840.jpg


Found to have a cure rate comparable to levofloxacin and meropenem and have been shown to be active against several strains of bacteria - Doribax (doripenem injection, 500 mg intravenous infusion) - has recently approved by the FDA for the treatment of complicated urinary tract infections and intra-abdominal infections.

Doribax is a product of Johnson and Johnson Pharmaceutical Research and Development, LLC.

Find more details from FDA News and J&J Press Release.



Permalink: Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections

Tags: Doribax  doripenem  injection  500  mg  intravenous  infusion  urinary  tract  infections  intraabdominal  infe 

Vote for Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins